02/14/2024 1:21 PM | Aridis Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 7:02 PM | Aridis Pharmaceuticals (Subject) Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
01/16/2024 5:05 AM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 8:40 AM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 8:43 AM | Aridis Pharmaceuticals (Filer)
| Form DEFA14A | |
11/06/2023 3:06 PM | Aridis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023 4:00 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
11/03/2023 5:15 AM | Aridis Pharmaceuticals (Filer)
| Form DEFA14A | |
09/13/2023 8:47 PM | Aridis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/08/2023 9:13 AM | Aridis Pharmaceuticals (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/07/2023 3:15 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 11:15 PM | Aridis Pharmaceuticals (Filer)
| Form EFFECT | |
07/21/2023 5:49 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
07/20/2023 4:18 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 7:00 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 2:01 PM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
07/17/2023 6:36 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
06/27/2023 2:15 PM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
06/15/2023 4:16 PM | Aridis Pharmaceuticals (Issuer) Patzer Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:09 PM | Aridis Pharmaceuticals (Issuer) KURLAND FRED (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:11 PM | Aridis Pharmaceuticals (Issuer) Jafri Hasan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:12 PM | Aridis Pharmaceuticals (Issuer) Windham-Bannister Susan Richards (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:13 PM | Aridis Pharmaceuticals (Issuer) Truong Vu (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 4:14 PM | Aridis Pharmaceuticals (Issuer) HAMILTON JOHN F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 5:13 AM | Aridis Pharmaceuticals (Filer)
| Form S-1/A | |
05/22/2023 4:31 PM | Aridis Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/22/2023 4:22 PM | Aridis Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
05/16/2023 1:26 PM | Aridis Pharmaceuticals (Filer)
| Form NT 10-Q | |
05/01/2023 5:15 AM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2023 3:30 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2023 3:53 PM | Aridis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |